DR. MARK CHRISTOPHER GENOVESE, M.D.
Osteopathic Medicine at Welch Rd, Palo Alto, CA
License number
California A052149
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
2
1000 Welch Rd, Palo Alto, CA 94304
879 Helena Dr, Sunnyvale, CA 94087
879 Helena Dr, Sunnyvale, CA 94087
Phone
(650) 498-4528
(650) 723-9656 (Fax)
(408) 732-9057
(650) 723-9656 (Fax)
(408) 732-9057
Organization information
See more information about MARK CHRISTOPHER GENOVESE at bizstanding.comMark Christopher Genovese M.D
1000 Welch Rd, Palo Alto, CA 94304
Industry:
Ret Drugs/Sundries
Internal Medicine, Medical Doctors:
Halsted Holman (Internal Medicine),Mark C. Genovese (Internal Medicine, Medical Doctor)
Professional information
Dr. Mark C Genovese, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
Mark C Genovese MD
1000 Welch Rd STE 203, Palo Alto 94304
(650) 723-5455 (Phone)
1000 Welch Rd STE 203, Palo Alto 94304
(650) 723-5455 (Phone)
Procedures:
Joint Drainage, Steroid Injections, Viscosupplementation With Hyaluronate
Conditions:
Adhesive Capsulitis, Arthritis, Behçet's Disease, Bursitis, Chronic Neck Pain, Degenerative Disc Disease, Dermatomyositis, Enthesopathy of Hip (incl. Trochanteric Bursitis), Enthesopathy of Knee (incl. Bursitis of Knee), Fibromyalgia, Giant Cell Arteritis, Gout, HenochâÂÂSchönlein Purpura (HSP), Low Back Pain, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Rheumatoid Arthritis, Sarcoidosis, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Vasculitis, Wegener's Granulomatosis
Certifications:
Internal Medicine, 1995, Rheumatology, 2013
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mark C Genovese MD
1000 Welch Rd STE 203, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
1000 Welch Rd STE 203, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1992
Stanford University
Graduated: 1993
Graduated: 1995
Graduated: 1998
Johns Hopkins University School Of Medicine
Graduated: 1992
Stanford University
Graduated: 1993
Graduated: 1995
Graduated: 1998
Mark Christopher Genovese, Palo Alto CA
Specialties:
Internal Medicine, Clinical & Laboratory Immunology, Rheumatology
Work:
Stanford Hospital and Clinics
1000 Welch Rd, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
1000 Welch Rd, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
Johns Hopkins University (1992)
Mark Christopher Genovese, Palo Alto CA
Specialties:
Rheumatologist
Address:
1000 Welch Rd, Palo Alto, CA 94304
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Rheumatology (Internal Medicine)
Stanford Hospital & Clinics - Fellowship - Rheumatology (Internal Medicine)
Antibody Profiling For Determination Of Patient Responsiveness
US Patent:
2008002, Jan 31, 2008
Filed:
Apr 18, 2007
Appl. No.:
11/788232
Inventors:
Wolfgang Hueber - Menlo Park CA, US
William Robinson - Palo Alto CA, US
Lawrence Steinman - Stanford CA, US
Paul Utz - Portola Valley CA, US
Mark Genovese - Stanford CA, US
William Robinson - Palo Alto CA, US
Lawrence Steinman - Stanford CA, US
Paul Utz - Portola Valley CA, US
Mark Genovese - Stanford CA, US
International Classification:
G01N 33/564
US Classification:
436507000
Abstract:
Compositions and methods are provided for prognostic classification of autoimmune disease patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of circulating blood levels of serum autoantibodies and/or cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Additionally, serum autoantibody and/or cytokine signature patterns can be utilized to monitor responses to therapy. Assessment of this signature pattern of autoantibodies and/or cytokines in a patient thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is rheumatoid arthritis.
Treatment Of Diseases Associated With Inflammation
US Patent:
2014006, Mar 6, 2014
Filed:
Aug 21, 2013
Appl. No.:
13/972614
Inventors:
Qian Wang - Palo Alto CA, US
Heidi H. Wong - San Francisco CA, US
Mark C. Genovese - Sunnyvale CA, US
Heidi H. Wong - San Francisco CA, US
Mark C. Genovese - Sunnyvale CA, US
International Classification:
A61K 31/4706, A61K 45/06, A61K 31/40
US Classification:
514275, 514313
Abstract:
Compositions and methods are provided for preventing or treating the pre-clinical early-stages of inflammatory diseases, including autoimmune diseases, degenerative inflammatory diseases, metabolic inflammatory diseases, chronic infection associated with inflammation, cancer associated with inflammation, and other inflammatory diseases by administration to an individual of an effective dose of a synergistic combination of active agents comprising or consisting essentially of an aminoquinoline, e.g. hydroxychloroquine, and a statin, e.g. atorvastatin. Each or both of the active agents can be formulated in various ways, including without limitation a solid oral dosage form.